Mechanisms and pathways of excess cholesterol removal from intracellular sites of accumulation to extracellular cholesterol acceptors remain poorly defined. To gain further insights, compounds known to affect cellular protein transport pathways were tested for their effects on high density lipoprotein (HDL)-mediated cholesterol efflux from cultured cells enriched with cholesterol. Monensin, nigericin, and brefeldin A inhibited the ability of HDL to decrease cellular cholesterol esterification, stimulate sterol biosynthesis, and promote the efflux of labeled cholesterol and cholesterol mass from fibroblasts and smooth muscle cells. HDL-mediated decrease in cell cholesterol esterification was inhibited up to 80% by these compounds compared with control incubations over an HDL concentration of 5-100 µg/ml and up to 18 h of incubation. Up-regulation of sterol biosynthesis after depletion of cell cholesterol by HDL increased over 10-fold; however, inclusion of monensin or brefeldin A during the incubation completely prevented the increase of sterol biosynthesis by HDL. Efflux of [H]cholesterol to HDL from prelabeled cells was inhibited up to 40% by these compounds, and this effect persisted when cholesterol esterification was blocked. Similarly, monensin and brefeldin A inhibited up to 50% of HDL-mediated cholesterol mass efflux relative to controls. Treatment of cells with cholesterol oxidase demonstrated an increase of intracellular cholesterol after exposure to monensin or nigericin and to a lesser extent with brefeldin A. These data show that monensin, nigericin, and brefeldin A sequester cholesterol from sites normally available for efflux by HDL. Since these compounds act by disruption of Golgi complex structure and function, a role for this intracellular organelle in transport of cholesterol between intracellular sites and the plasma membrane for eventual removal by extracellular acceptors such as HDL is suggested.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				D. A. Prosdocimo, D. C. Douglas, A. M. Romani, W. C. O'Neill, and G. R. Dubyak Autocrine ATP release coupled to extracellular pyrophosphate accumulation in vascular smooth muscle cells Am J Physiol Cell Physiol, April 1, 2009; 296(4): C828 - C839. [Abstract] [Full Text] [PDF]

				F. J. Field, K. Watt, and S. N. Mathur Origins of intestinal ABCA1-mediated HDL-cholesterol J. Lipid Res., December 1, 2008; 49(12): 2605 - 2619. [Abstract] [Full Text] [PDF]

				T. D. Southall, S. Terhzaz, P. Cabrero, V. R. Chintapalli, J. M. Evans, J. A. T. Dow, and S.-A. Davies Novel subcellular locations and functions for secretory pathway Ca2+/Mn2+-ATPases Physiol Genomics, September 14, 2006; 26(1): 35 - 45. [Abstract] [Full Text] [PDF]

				H. Zheng, R. S. Kiss, V. Franklin, M.-D. Wang, B. Haidar, and Y. L. Marcel ApoA-I Lipidation in Primary Mouse Hepatocytes: SEPARATE CONTROLS FOR PHOSPHOLIPID AND CHOLESTEROL TRANSFERS J. Biol. Chem., June 3, 2005; 280(22): 21612 - 21621. [Abstract] [Full Text] [PDF]

				P. Matarrese, A. Tinari, E. Mormone, G. A. Bianco, M. A. Toscano, B. Ascione, G. A. Rabinovich, and W. Malorni Galectin-1 Sensitizes Resting Human T Lymphocytes to Fas (CD95)-mediated Cell Death via Mitochondrial Hyperpolarization, Budding, and Fission J. Biol. Chem., February 25, 2005; 280(8): 6969 - 6985. [Abstract] [Full Text] [PDF]

				M. Walter, N. R. Forsyth, W. E. Wright, J. W. Shay, and M. G. Roth The Establishment of Telomerase-immortalized Tangier Disease Cell Lines Indicates the Existence of an Apolipoprotein A-I-inducible but ABCA1-independent Cholesterol Efflux Pathway J. Biol. Chem., May 14, 2004; 279(20): 20866 - 20873. [Abstract] [Full Text] [PDF]

				J.-R. Nofer, R. Feuerborn, B. Levkau, A. Sokoll, U. Seedorf, and G. Assmann Involvement of Cdc42 Signaling in ApoA-I-induced Cholesterol Efflux J. Biol. Chem., December 26, 2003; 278(52): 53055 - 53062. [Abstract] [Full Text] [PDF]

				G. Dagher, N. Donne, C. Klein, P. Ferre, and I. Dugail HDL-mediated cholesterol uptake and targeting to lipid droplets in adipocytes J. Lipid Res., October 1, 2003; 44(10): 1811 - 1820. [Abstract] [Full Text] [PDF]

				U. Igbavboa, J. M. Pidcock, L. N. A. Johnson, T. M. Malo, A. E. Studniski, S. Yu, G. Y. Sun, and W. G. Wood Cholesterol Distribution in the Golgi Complex of DITNC1 Astrocytes Is Differentially Altered by Fresh and Aged Amyloid beta -Peptide-(1-42) J. Biol. Chem., May 2, 2003; 278(19): 17150 - 17157. [Abstract] [Full Text] [PDF]

				M. C. Marchetti, B. Di Marco, G. Cifone, G. Migliorati, and C. Riccardi Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation Blood, January 15, 2003; 101(2): 585 - 593. [Abstract] [Full Text] [PDF]

				W. S. Garver, K. Krishnan, J. R. Gallagos, M. Michikawa, G. A. Francis, and R. A. Heidenreich Niemann-Pick C1 protein regulates cholesterol transport to the trans-Golgi network and plasma membrane caveolae J. Lipid Res., April 1, 2002; 43(4): 579 - 589. [Abstract] [Full Text] [PDF]

				A. VON ECKARDSTEIN, C. LANGER, T. ENGEL, I. SCHAUKAL, A. CIGNARELLA, J. REINHARDT, S. LORKOWSKI, Z. LI, X. ZHOU, P. CULLEN, et al. ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages FASEB J, July 1, 2001; 15(9): 1555 - 1561. [Abstract] [Full Text] [PDF]

				B. Haidar, S. Mott, B. Boucher, C. Y. Lee, M. Marcil, and J. Genest , Jr. Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts J. Lipid Res., February 1, 2001; 42(2): 249 - 257. [Abstract] [Full Text]

				A. von Eckardstein, J.-R. Nofer, and G. Assmann High Density Lipoproteins and Arteriosclerosis : Role of Cholesterol Efflux and Reverse Cholesterol Transport Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 13 - 27. [Abstract] [Full Text] [PDF]

				M. E. Brousseau, G. P. Eberhart, J. Dupuis, B. F. Asztalos, A. L. Goldkamp, E. J. Schaefer, and M. W. Freeman Cellular cholesterol efflux in heterozygotes for Tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size J. Lipid Res., July 1, 2000; 41(7): 1125 - 1135. [Abstract] [Full Text]

				W. S. Garver, R. A. Heidenreich, R. P. Erickson, M. A. Thomas, and J. M. Wilson Localization of the murine Niemann-Pick C1 protein to two distinct intracellular compartments J. Lipid Res., May 1, 2000; 41(5): 673 - 687. [Abstract] [Full Text]

				P Pujuguet, M Simian, J Liaw, R Timpl, Z Werb, and M. Bissell Nidogen-1 regulates laminin-1-dependent mammary-specific gene expression J. Cell Sci., January 3, 2000; 113(5): 849 - 858. [Abstract] [PDF]

				C. G. Panousis and S. H. Zuckerman Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-{gamma} J. Lipid Res., January 1, 2000; 41(1): 75 - 83. [Abstract] [Full Text]

				J. F. Oram, A. J. Mendez, J. Lymp, T. J. Kavanagh, and C. L. Halbert Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: lack of effect with Tangier disease cells J. Lipid Res., October 1, 1999; 40(10): 1769 - 1781. [Abstract] [Full Text]

				M. G. Cifone, G. Migliorati, R. Parroni, C. Marchetti, D. Millimaggi, A. Santoni, and C. Riccardi Dexamethasone-Induced Thymocyte Apoptosis: Apoptotic Signal Involves the Sequential Activation of Phosphoinositide-Specific Phospholipase C, Acidic Sphingomyelinase, and Caspases Blood, April 1, 1999; 93(7): 2282 - 2296. [Abstract] [Full Text] [PDF]

				W. Drobnik, G. Liebisch, C. Biederer, B. Trumbach, G. Rogler, P. Muller, and G. Schmitz Growth and Cell Cycle Abnormalities of Fibroblasts From Tangier Disease Patients Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 28 - 38. [Abstract] [Full Text] [PDF]

				M. Marcil, L. Yu, L. Krimbou, B. Boucher, J. F. Oram, J. S. Cohn, and J. Genest Jr Cellular Cholesterol Transport and Efflux in Fibroblasts Are Abnormal in Subjects With Familial HDL Deficiency Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 159 - 169. [Abstract] [Full Text] [PDF]

				G. P. Eberhart, A. J. Mendez, and M. W. Freeman Decreased Cholesterol Efflux from Fibroblasts of a Patient without Tangier Disease, but with Markedly Reduced High Density Lipoprotein Cholesterol Levels J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 836 - 846. [Abstract] [Full Text]

				A.T. Remaley, U.K. Schumacher, J.A. Stonik, B.D. Farsi, H. Nazih, and H.B. Brewer Decreased Reverse Cholesterol Transport from Tangier Disease Fibroblasts : Acceptor Specificity and Effect of Brefeldin on Lipid Efflux Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1813 - 1821. [Abstract] [Full Text]

				J. D. Smith, M. Miyata, M. Ginsberg, C. Grigaux, E. Shmookler, and A. S. Plump Cyclic AMP Induces Apolipoprotein E Binding Activity and Promotes Cholesterol Efflux from a Macrophage Cell Line to Apolipoprotein Acceptors J. Biol. Chem., November 29, 1996; 271(48): 30647 - 30655. [Abstract] [Full Text] [PDF]

				W. J. Johnson, R. T. Fischer, M. C. Phillips, and G. H. Rothblat Efflux of Newly Synthesized Cholesterol and Biosynthetic Sterol Intermediates from Cells J. Biol. Chem., October 20, 1995; 270(42): 25037 - 25046. [Abstract] [Full Text] [PDF]

				A. E. Bortnick, G. H. Rothblat, G. Stoudt, K. L. Hoppe, L. J. Royer, J. McNeish, and O. L. Francone The Correlation of ATP-binding Cassette 1 mRNA Levels with Cholesterol Efflux from Various Cell Lines J. Biol. Chem., September 8, 2000; 275(37): 28634 - 28640. [Abstract] [Full Text] [PDF]

				F. Blanchard, L. Duplomb, Y. Wang, O. Robledo, E. Kinzie, V. Pitard, A. Godard, Y. Jacques, and H. Baumann Stimulation of Leukemia Inhibitory Factor Receptor Degradation by Extracellular Signal-regulated Kinase J. Biol. Chem., September 8, 2000; 275(37): 28793 - 28801. [Abstract] [Full Text] [PDF]

				A. J. Mendez, G. Lin, D. P. Wade, R. M. Lawn, and J. F. Oram Membrane Lipid Domains Distinct from Cholesterol/Sphingomyelin-Rich Rafts Are Involved in the ABCA1-mediated Lipid Secretory Pathway J. Biol. Chem., January 26, 2001; 276(5): 3158 - 3166. [Abstract] [Full Text] [PDF]

				S. El Bawab, H. Birbes, P. Roddy, Z. M. Szulc, A. Bielawska, and Y. A. Hannun Biochemical Characterization of the Reverse Activity of Rat Brain Ceramidase. A CoA-INDEPENDENT AND FUMONISIN B1-INSENSITIVE CERAMIDE SYNTHASE J. Biol. Chem., May 11, 2001; 276(20): 16758 - 16766. [Abstract] [Full Text] [PDF]

				E. B. Neufeld, A. T. Remaley, S. J. Demosky, J. A. Stonik, A. M. Cooney, M. Comly, N. K. Dwyer, M. Zhang, J. Blanchette-Mackie, S. Santamarina-Fojo, et al. Cellular Localization and Trafficking of the Human ABCA1 Transporter J. Biol. Chem., July 13, 2001; 276(29): 27584 - 27590. [Abstract] [Full Text] [PDF]